Clinical trial
Efficacy and Safety of CRO-SBT Performed in Children With Acute Bacterial Infection
NCT04066621 is registered in ClinicalTrials.gov with Xiangbei Welman Pharmaceutical Co., Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of CRO-SBT Performed in Children With Acute Bacterial Infection
- Lead sponsor
- Xiangbei Welman Pharmaceutical Co., Ltd
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- April 28, 2015
- Completion date
- May 27, 2017
- Enrollment
- 30 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
respiratory tract infections, urinary tract infections in children